Back to Top
World Gastroenterology Organisation
World Gastroenterology Organisation
WGO: Facebook WGO: Twitter

World Hepatitis Day 2017: Eliminating Hepatitis

World Hepatitis Day 2017

Eliminate Viral Hepatitis by 2030

"Together we can all put a human face to the elimination of viral hepatitis."

WGO secretariat staff celebrating World Hepatitis Day
in front of the Milwaukee Art Museum Calatrava in Milwaukee, Wisconsin, USA

"Recognizing the consequences of viral hepatitis and its effect on the global community, specifically the 400 million people worldwide living with this virus, and in support of World Hepatitis Day, WGO joins its partners in the goal of eliminating viral hepatitis globally as a public health threat by 2030!"

Professor David Bjorkman, President of World Gastroenterology Organisation

What is World Hepatitis Day?

World Hepatitis Day is an awareness campaign organized by the World Hepatitis Alliance. World Hepatitis Day is celebrated every 28 July to bring about the awareness of the global burden of viral hepatitis, with the primary campaign goal of eliminating viral hepatitis by 2030.

“Acute viral hepatitis (AVH) is a systemic infection predominantly affecting the liver. It is most often caused by viruses that are hepatotropic (hepatitis A, B, C, D, and E).

"It is time to make World Hepatitis Day, not an awareness moment, but a remembrance landmark. Let us tackle Viral Hepatitis and score for a future Hepatitis-Free World!"

Professor Guilherme Macedo, WGO Treasurer and Director of the WGO Porto Gastroenterology and Hepatology Training Center

Other viral infections may also occasionally affect the liver, such as cytomegalovirus (CMV), herpes simplex, coxsackievirus, and adenovirus. Whereas hepatitis A and E are self-limiting, infection with hepatitis C and to a lesser extent hepatitis B usually become chronic” - Read more from the WGO Acute Viral Hepatitis Guideline.

Why is World Hepatitis Day Important?

“Viral hepatitis and its consequences (cirrhosis, liver failure, liver cancer, death), have been ignored far too long. Hepatitis B and C alone affect over 1 in 12 of the world’s population and cause more chronic disease and death than HIV, TB or malaria. Both hepatitis B and C are preventable and hepatitis C can be cured. Several countries have made it national policy to completely eliminate hepatitis C, including Georgia, Mongolia, Egypt, Pakistan, Portugal and Australia. It is time to unite and decide to eliminate hepatitis C globally. At the same time we must dedicate ourselves to eliminating hepatitis B through true universal vaccination, including the birth dose, with a vaccine that has been available since 1982! Then, like smallpox before it and polio, now down to fewer than 100 new cases in only 2 countries worldwide, hepatitis B can become part of our ancient medical history.”

Professor Douglas R. LaBrecque, Chair of the WGO Hepatology Interest Group


What Is WGO’s Role in Joining the Effort to Eliminate Viral Hepatitis By 2030?

World Digestive Health Day 2018

The World Gastroenterology Organisation (WGO) will raise awareness of Viral Hepatitis, B and C in 2018 through its annual public advocacy and awareness campaign, World Digestive Health Day (WDHD).

"On behalf of the WGO Foundation, we would like to express our continued support for World Hepatitis Day and declare action. WGO has in place various education and training programs focused on hepatology and resources that are used to help create awareness of viral hepatitis, which is supported through the work of the WGO and the WGO Foundation. It is our hope that you will join us in our efforts to encourage active participation in eliminating viral hepatitis and other important diet and the gut related digestive diseases through advocacy programs such as "World Digestive Health Day" worldwide."

Professor Cihan Yurdaydin, President-Elect and Chair of the WGO Foundation

WDHD is celebrated each year on May 29th with associated activities and initiatives continuing throughout and beyond the campaign year. WDHD will provide gastroenterologists, their patients and the public, with an understanding of the prevention, prevalence, diagnosis, management and/or treatment of Viral Hepatitis, B and C.

The campaign will be led by Brian McMahon, MD (U.S.A.) and Yun-Fan Liaw, MD (Taiwan).

WGO Training Centers

Since 2001, over 3,400 professionals have received training through the various educational programs offered at the WGO Training Centers. Located in developing countries throughout the world, each WGO Training Center provides trainees with the opportunity to enhance their skills and further their education in gastroenterology, hepatology, endoscopy, oncology, and GI surgery. Each Center offers comprehensive training, ranging from multi-day workshops on special topics to four-year sub-specialty internships that include theoretical courses and practical applications of techniques. The Training Centers promulgate locally relevant knowledge and develop appropriate skills among medical practitioners and health care workers from low-resource countries. Below are the WGO Training Centers with a primary focus on Hepatology related activities:

Supporting WGO Global Guidelines and Cascades

The WGO Guidelines and Cascades library contains over 20 practice guidelines written from a global standpoint and published for viewing and download on the WGO website. Cascade-based guidelines offer various treatment options for diagnosis and treatment depending on the resources available in different parts of the world. The six supporting WGO Global Guidelines and Cascades listed below are available in different languages and focus on hepatitis and related liver disease topic areas:

e-WGN Expert Point of View (EPOV) Articles Hepatology Collection

The e-WGN Expert Point of View (EPOV) articles listed below are a part of the Hepatology Collection and are available for viewing on the WGO Website. Click the article title(s) below to begin reading!

Nonalcoholic Fatty Liver Disease – A Growing Public Health Problem
Davor Stimac, MD, PhD
Ivana Mikolasevic, MD, PhD
Vol. 20, Issue #4 (January 2016)

Outcomes and Treatments of Dual Chronic Hepatitis B and C
Chun-Jen Liu, MD, PhD
Vol. 19, Issue #4 (January 2015)

HIV/HBV and HIV/HCV Co-infection in Sub-Saharan Africa: Transmission, Disease Outcomes, and Treatment Options
Mark W. Sonderup, MD
C. Wendy Spearman, MD
Vol. 19, Issue #4 (January 2015)

WGO Lectureship, Georges Brohée Medal and Lecture: New Views on NASH Pathogenesis – How Should They Inform Management?
Geoffrey C. Farrell, MD, FRACP
Vo0l. 18, Issue #3 (September 2013)

From Obesity to Fatty Liver/NASH: Two Parallel Epidemics
Sofia Carvalhana, MD
Helena Cortez-Pinto, MD, PhD
Vol. 18, Issue #2 (July 2013)

New Era of Antiviral Therapy for Chronic Hepatitis C Infection: Implications on Global Health
Joseph K. Lim, MD
Vol. 17, Issue #4 (December 2012)

Part II: Global Burden Of Liver Disease: A True Burden on Health Sciences and Economies!!
S. K. Sarin, MD, DM
Rakhi Maiwall, MD, DM
Vol. 17, Issue #3 (October 2012)

Global Burden Of Liver Disease: A True Burden on Health Sciences and Economies!!
S. K. Sarin, MD, DM
Rakhi Maiwall, MD, DM
Vol. 17, Issue #2 (July 2012)

Acute Hepatitis E
Wasim Jafri, MD, FRCP, FACG, FACP
Om Parkash, MBBS, FCPS, FCPS (GI), MSc, FACP
Vol. 17, Issue #1 (March 2012)

Educational Programs

In collaboration with WGO, the International Coalition of Hepatology Education Providers (IC-HEP) created an audiocast series focused on the management of Hepatitis C in Latin America.

This series includes expert presentations delivered by:

Through educational collaboration with WGO, IC-HEP also created webcasts on Hepatitis C and HCC:

How Can YOU Contribute To The Goal Of Eliminating Hepatitis By 2030?

#ShowYourFace World Hepatitis Day Campaign

The #ShowYourFace World Hepatitis Day photo campaign focuses on individual human faces to highlight the relevance of hepatitis to everyone.

Access the #ShowYourFace selfie tool here.

World Hepatitis Day 2017 on Social Media

Use the following hashtags when posting about hepatitis on social media!

  • #WorldHepatitisDay
  • #NoHep
  • #ShowYourFace

For more information on participating through social media, download the World Hepatitis Alliance Social Media Toolkit here!

Also don't forget to like and follow us on Facebook and Twitter for information on where to find WGO resources in support of World Hepatitis Day!

World Hepatitis Day 2017 Campaign Toolkit

Download the World Hepatitis Day 2017 Campaign Toolkit, provided by the World Hepatitis Alliance, for more ideas on how you can participate in the World Hepatitis Day 2017 Campaign here!

Additional Resources for More Information

Click on the links below to learn more about World Hepatitis Day and join the global movement!

Other Notable Announcements

Liver-Related Presentations at the World Congress of Gastroenterology at ACG 2017

The liver-related presentations and optional learning luncheons listed below will be offered at the World Congress of Gastroenterology at ACG2017, October 14-15, in Orlando, Florida:

Postgraduate Course

Saturday, October 14, 2017

Symposium C: Updates in Liver Disease

  • Autoimmune Liver Disorders
  • Diagnosis and Multi-modality Management of Hepatocellular Carcinoma
  • Management of Alcoholic Hepatitis

Saturday Optional Learning Luncheons

$75 per person per lunch. Separate registration required.

  • Updates in the Management of Portal Hypertension
  • HBV Reactivation with Immunosuppressive Therapy and Management During Pregnancy

Sunday, October 15, 2017 

Symposium E: Viral Hepatitis

  • The Global Burden of Hepatitis C
  • Goals of Therapy in HBV
  • Therapy for Hepatitis C

Saturday Optional Learning Luncheons

$75 per person per lunch. Separate registration required.

  • NAFLD and NASH: Diagnostic Tools and Management
  • Approach to Abnormal Liver Function Tests

WCOG Scientific Meeting

Monday, October 16, 2017 

Symposia 2B: Advances in Hepatitis C Therapy: 2017 Update

  • Global Eradication of HCV: Can It Be Achieved?
  • Current Treatment of HCV
  • Treatment of Special Populations With HCV

Simultaneous Plenary Sessions

Session 1A: Liver

  • Integrated Efficacy and Safety of Glecaprevir/Pibrentasvir to Treat HCV Genotype 1-6 Infection in Patients Without Cirrhosis Including HIV Co-Infection
  • Degree of Estimated Fibrosis in Asymptomatic Subjects With Non-Alcoholic Fatty Liver Disease Correlates With Higher Cardiovascular Risk
  • Validity of Non-Invasive Fibrosis Scores to Detect Advanced Fibrosis in Patients With Type 2 Diabetes With Suspected Non-Alcoholic Fatty Liver Disease

Tuesday, October 17, 2017 

Breakfast K: Hot Topics in Liver Disease

$60 per person per breakfast. Separate registration required.

  • Current and Emerging Treatment Options for NASH: What You Can Do Now and What Is Coming in the Near Future
  • Management of Alcoholic Hepatitis
  • Clinical Presentation and Management of DILI

Simultaneous Symposia Sessions

Symposia 3D: The Global State of Hepatitis B: 2017

  • Global Epidemiology of Hepatitis B: How Is it Acquired and How Can it Be Prevented?
  • Hepatitis B: Who Should Be Treated and With What?
  • Emerging and Future Therapies for Hepatitis B: Is a Cure on the Horizon?

Simultaneous Plenary Sessions

(Free Paper / Abstract Presentations)

  • Session 3C: Best of WCOG – Liver Topics (Presented in Spanish)

Wednesday, October 18, 2017

Simultaneous Plenary Sessions

  • Session 4A: Liver

And More!

Liver is just one of the many topics to be covered at the World Congress of Gastroenterology at ACG 2017.  Register today!

American Association for the Study of Liver Diseases (AASLD) - The Liver Meeting® 2017

Visit WGO at booth #709 at the American Association for the Study of Liver Diseases - The Liver Meeting® 2017: Walter E. Washington Convention Center, Washington DC, October 20 -24!